G
Goodarz Danaei
Researcher at Harvard University
Publications - 192
Citations - 67656
Goodarz Danaei is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 59, co-authored 173 publications receiving 55837 citations. Previous affiliations of Goodarz Danaei include Institute for Health Metrics and Evaluation & Imperial College London.
Papers
More filters
Journal ArticleDOI
Stunting risk of orphans by caregiver and living arrangement in low-income and middle-income countries
Jocelyn E. Finlay,Günther Fink,Dana Charles McCoy,L Carolina Tavárez,Jeanne Chai,Goodarz Danaei,Majid Ezzati,Wafaie W. Fawzi,Mary C. Smith Fawzi +8 more
TL;DR: The results suggest that the adverse effects of a parental loss can be mitigated if appropriate support is provided, indicating the potential benefits of the surviving parents staying with their children.
Journal ArticleDOI
Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United States.
TL;DR: A substantially larger proportion of blacks have a high risk of fatal CVD and bear a large share of CVD deaths, and an intervention that targeted multiple risk factors among this group was estimated to reduce black-white differences in CVD rates.
Journal ArticleDOI
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.
Rishi J. Desai,Daniel H. Solomon,Sebastian Schneeweiss,Goodarz Danaei,Katherine P. Liao,Seoyoung C. Kim +5 more
TL;DR: Treatment with TNF-&agr; inhibitors was not associated with a reduced risk of incident hypertension compared with nonbiologics in rheumatoid arthritis patients, and a known association between leflunomide (a nonbiologic disease modifying agent) and hypertension was evaluated.
Journal ArticleDOI
Cost‐effectiveness analysis of integrating screening and treatment of selected non‐communicable diseases into HIV/AIDS treatment in Uganda
David Sando,Alexander Kintu,Samson Okello,Peter Chris Kawungezi,David Guwatudde,Gerald Mutungi,Winnie Muyindike,Nicolas A Menzies,Goodarz Danaei,Stéphane Verguet +9 more
TL;DR: This study aims to study the cost‐effectiveness of basic NCD‐HIV integration in a Ugandan setting.
Journal ArticleDOI
Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis.
TL;DR: In this paper, a cross-sectional study using a sample representative of the English population aged 30-84 years was conducted to determine risk factor levels required to exceed the risk threshold for statin therapy, and to estimate the number of adults in England who would require statin treatment under the 2014 NICE guidelines.